The authors reported that the enhanced expression of AQP5 in K562 cells caused increased cell growth, while small interfering RNA aiming AQP5 decreased cell growth in both K562 and LAMA84 CML cells. This evidence concerns the gene AQP5 and chronic myelogenous leukemia, BCR-ABL1 positive.